ENDLOS-TURBO PUT - AMGEN | Delayed Deutsche Boerse AG 11:34:40 2024-06-03 EDT | ||
| 5.13 EUR | -7.90% |
|
| 1 month | -34.62% | ||
| 3 months | -31.82% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-03 | 5.13 | -7.90% |
| 24-05-31 | 5.57 | -2.45% |
| 24-05-30 | 5.71 | -9.22% |
| 24-05-29 | 6.29 | +5.18% |
| 24-05-28 | 5.98 | +16.57% |
Delayed Quote Deutsche Boerse AG
Last update June 03, 2024 at 11:34 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ4SFL |
| ISIN | DE000DJ4SFL5 |
| Date issued | 2023-08-10 |
| Strike | 363.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 9.66 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11 € |
|---|---|
| Lowest since issue | 3.57 € |
| Spread | 0.02 € |
| Spread % | 0.39% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
